Ann: Imugene and NeoImmuneTech to Improve Cancer Treatments, page-57

it is possible funds will need to be sourced be for this collaboration. This, plus increasing remuneration and growing staff numbers means the kitty is dwindling faster than originally expected. I expect many will point to cash balance, but the balance was extremely high with the last begging for capital. Some of the funds were retrieved today, but a lot more is needed. Every added project/collaboration brings instant money to those arranging it, I thought CF333 already works? Inject it into the tumour and bingo, a cure. Apparently it needs a lot of other resources (friends) to actually work.